Relationships Between Exposure to Gestational Diabetes Treatment and Neonatal Anthropometry: Evidence from the Born in Bradford (BiB) Cohort
-
Published:2023-11-29
Issue:
Volume:
Page:
-
ISSN:1092-7875
-
Container-title:Maternal and Child Health Journal
-
language:en
-
Short-container-title:Matern Child Health J
Author:
Martine-Edith GilberteORCID, Johnson William, Petherick Emily S.
Abstract
Abstract
Objectives
To examine the relationships between gestational diabetes mellitus (GDM) treatment and neonatal anthropometry.
Methods
Covariate-adjusted multivariable linear regression analyses were used in 9907 offspring of the Born in Bradford cohort. GDM treatment type (lifestyle changes advice only, lifestyle changes and insulin or lifestyle changes and metformin) was the exposure, offspring born to mothers without GDM the control, and birth weight, head, mid-arm and abdominal circumference, and subscapular and triceps skinfold thickness the outcomes.
Results
Lower birth weight in offspring exposed to insulin (− 117.2 g (95% CI − 173.8, − 60.7)) and metformin (− 200.3 g (− 328.5, − 72.1)) compared to offspring not exposed to GDM was partly attributed to lower gestational age at birth and greater proportion of Pakistani mothers in the treatment groups. Higher subscapular skinfolds in offspring exposed to treatment compared to those not exposed to GDM was partly attributed to higher maternal glucose concentrations at diagnosis. In fully adjusted analyses, offspring exposed to GDM treatment had lower weight, smaller abdominal circumference and skinfolds at birth than those not exposed to GDM. Metformin exposure was associated with smaller offspring mid-arm circumference (− 0.3 cm (− 0.6, − 0.07)) than insulin exposure in fully adjusted models with no other differences found.
Conclusions for Practice
Offspring exposed to GDM treatment were lighter and smaller at birth than those not exposed to GDM. Metformin-exposed offspring had largely comparable birth anthropometric characteristics to those exposed to insulin.
Funder
Loughborough University NIHR Leicester Biomedical Research Centre MRC NEW INVESTIGATOR RESEARCH GRANT
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health,Epidemiology
Reference34 articles.
1. Adams, K. M., Li, H., Nelson, R. L., Ogburn, J., Danilenko-Dixon, D. R., Sunkel, D. R., Bofill, J. A., Hill, W. C., Maurus, J. N., Carpenter, R. J., Sandmire, H. F., & Levine, E. M. (1998). Sequelae of unrecognized gestational diabetes. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/S0002-9378(98)70339-4 2. Ainuddin, J., Karim, N., Hasan, A. A., & Naqvi, S. A. (2015). Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country. A randomized control trial. Diabetes Research and Clinical Practice,107(2), 290–299. https://doi.org/10.1016/j.diabres.2014.10.001 3. Baptiste-Roberts, K., Nicholson, W. K., Wang, N. Y., & Brancati, F. L. (2012). Gestational diabetes and subsequent growth patterns of offspring: The national collaborative perinatal project. Maternal and Child Health Journal,16(1), 125–132. https://doi.org/10.1007/s10995-011-0756-2 4. Barrett, H. L., Gatford, K. L., Houda, C. M., De Blasio, M. J., Mcintyre, H. D., Callaway, L. K., Nitert, M. D., Coat, S., Owens, J. A., Hague, W. M., & Rowan, J. A. (2013). Maternal and neonatal circulating markers ofmetabolic and cardiovascular risk in themetformin in gestational diabetes (mig) trial. Diabetes Care,36(3), 529–536. https://doi.org/10.2337/dc12-1097 5. Brand, J. S., West, J., Tuffnell, D., Bird, P. K., Wright, J., Tilling, K., & Lawlor, D. A. (2018). Gestational diabetes and ultrasound-assessed fetal growth in south Asian and white European women: Findings from a prospective pregnancy cohort. BMC Medicine,16(1), 1–13. https://doi.org/10.1186/s12916-018-1191-7
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|